Latest Posts
AbbVie’s SKYRIZI Shows Promise for Crohn’s Disease: 55% Remission Rate Offers New Hope
A Breakthrough That Could Change Treatment Landscapes For anyone living with Crohn’s disease, the constant search for effective treatments that actually work…
When Crohn’s Disease Masquerades as Another Condition: A Critical Lesson in Accurate Diagnosis
For many of us living with Crohn’s disease, the journey to diagnosis can feel like navigating a medical maze. But what happens when even experienced healthcare…
New Research Reveals Critical Differences in Cancer Risk from IBD-Related Precancerous Lesions
If you’re living with inflammatory bowel disease, the possibility of developing colorectal cancer has likely crossed your mind during quiet moments between…
From Needle Phobia to New Beginnings: My Journey Starting Biologic Treatment
This story represents a composite of common IBD experiences and is presented to help readers feel less alone in their journey. The Moment Everything Changed My…
New Subcutaneous Infliximab Data Offers Hope for IBD Patients After Treatment Interruptions
A Breakthrough for Those Who’ve Had to Stop Their Medication If you’ve ever had to pause your infliximab treatment due to surgery, infection, or other health…
This Week in IBD: Your Weekly Roundup for March 3-9, 2026
Welcome to This Week’s Roundup Welcome back to our weekly digest of the latest IBD content! This week, we published 7 comprehensive articles covering…
